AbbVie Inc.
ANTI-EGFR ANTIBODY DRUG CONJUGATES (ADC) AND USES THEREOF

Last updated:

Abstract:

Provided herein are antibody-drug conjugates that bind EGFR, in particular human EGFR, their methods of making, and their uses to treat patients having cancer.

Status:
Application
Type:

Utility

Filling date:

4 Sep 2018

Issue date:

18 Jun 2020